2m 2m 2m 2m 2m 2m 2m
Eli Lilly & Co (LLY)
NYSE
$1,138.88+$2.77 (+0.24%)
Price as of Sep 15, 2026 7:58 PM EDT- $1.0TMarket Cap
- 49.50%1-Year Change
- Drug Manufacturers - GeneralIndustry
Eli Lilly & Co (LLY)
$1,138.88+$2.77 (+0.24%)
LLY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1,136.11 | ||
Change | -$2.17 (-0.19%) | ||
Open | $1,156.63 | ||
High | $1,161.00 | ||
Low | $1,131.59 | ||
Previous Close | $1,138.28 | ||
Volume | 1,887,654 | ||
30-Day Average Volume | 2,435,072 | ||
1-Week Change | 1.09% | ||
1-Month Change | -3.73% | ||
1-Year Change | 49.50% | ||
3-Year Change | 101.47% | ||
5-Year Change | 408.65% | ||
Fundamentals | |||
Shares Outstanding | 891.4M | ||
Total Assets | $142.3B | ||
Market Cap | $1.0T | ||
Enterprise Value | $1.1T | ||
Period: QTR TTM FY | |||
Revenue | $23.0B | ||
Net Income | $7.1B | ||
Free Cash Flow | $10.7B | ||
EBIT | $9.2B | ||
EBITDA | $9.8B | ||
Net Working Capital | $16.9B | ||
EPS | $7.94 | ||
Enterprise Value/EBITDA | 108 | ||
Enterprise Value/Revenue | 46 | ||
P/B | 30 | ||
P/E | 143 | ||
PEG | -37 | ||
Price/Free Cash Flow | 95 | ||
Price/Operating Cash Flow | 95 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 0.61% | ||
Trailing Annual Dividend Yield | 0.59% | ||
Ex-Dividend Date | 08/14/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield